These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37423952)

  • 1. ZNF143 facilitates the growth and migration of glioma cells by regulating KPNA2-mediated Hippo signalling.
    Chen Y; Li J; Ma J; Bao Y
    Sci Rep; 2023 Jul; 13(1):11097. PubMed ID: 37423952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ_0079593 promotes glioma development through regulating KPNA2 expression by sponging miR-499a-5p.
    Yang Z; Li C; Fan XY; Liu LJ
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(3):1288-1301. PubMed ID: 32096160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.
    Song Y; Shao L; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Shen S; Chen J; Li Z; Liu Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):248. PubMed ID: 31186064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway.
    Kong Q; Li J; Zhao L; Shi P; Liu X; Bian C; Liu J; Liu T
    Virol J; 2021 Oct; 18(1):214. PubMed ID: 34717661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development.
    Hu Y; Zhang R; Lu S; Zhang W; Wang D; Ge Y; Jiang F; Qin X; Liu Y
    Int J Biol Sci; 2023; 19(7):2034-2052. PubMed ID: 37151881
    [No Abstract]   [Full Text] [Related]  

  • 6. LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP.
    Shi Y; Geng D; Zhang Y; Zhao M; Wang Y; Jiang Y; Yu R; Zhou X
    J Mol Neurosci; 2019 May; 68(1):38-48. PubMed ID: 30771084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Karyopherin α 2 promotes proliferation, migration and invasion through activating NF-κB/p65 signaling pathways in melanoma cells.
    Yang F; Li S; Cheng Y; Li J; Han X
    Life Sci; 2020 Jul; 252():117611. PubMed ID: 32243925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway.
    Shi C; Sun L; Liu S; Zhang E; Song Y
    Med Sci Monit; 2020 Mar; 26():e921087. PubMed ID: 32147666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling.
    Zhou Y; Shan T; Ding W; Hua Z; Shen Y; Lu Z; Chen B; Dai T
    J Cell Physiol; 2018 Aug; 233(8):5805-5814. PubMed ID: 29215734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
    Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
    Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and significance of Hippo/YAP signaling in glioma progression.
    Zhang H; Geng D; Gao J; Qi Y; Shi Y; Wang Y; Jiang Y; Zhang Y; Fu J; Dong Y; Gao S; Yu R; Zhou X
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27718125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p.
    Lu P; Jiang Y; Xia Z
    Anticancer Drugs; 2023 Jan; 34(1):144-154. PubMed ID: 36539367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myosin light chain 9 promotes the proliferation, invasion, migration and angiogenesis of colorectal cancer cells by binding to Yes-associated protein 1 and regulating Hippo signaling.
    Feng M; Dong N; Zhou X; Ma L; Xiang R
    Bioengineered; 2022 Jan; 13(1):96-106. PubMed ID: 34974798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
    Le TPH; Nguyen NTT; Le DDT; Anwar MA; Lee SY
    Cell Commun Signal; 2023 Jun; 21(1):149. PubMed ID: 37337213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 10 promotes growth and invasion of glioma cells by up-regulating KPNA 2
    Zhang Z; Huang X; Li J; Fan H; Yang F; Zhang R; Yang Y; Feng S; He D; Sun W; Xin T
    J Cancer Res Ther; 2019; 15(4):927-932. PubMed ID: 31436254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
    Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
    FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Li L; Dong L; Wang Y; Zhang X; Yan J
    Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma.
    Guo C; Liang C; Yang J; Hu H; Fan B; Liu X
    Oncol Rep; 2019 May; 41(5):2753-2761. PubMed ID: 30896861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation.
    Lin F; Gao L; Su Z; Cao X; Zhan Y; Li Y; Zhang B
    Oncol Rep; 2018 Jul; 40(1):179-194. PubMed ID: 29781035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.